Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-05-06

Clinical Trial Update: Paclitaxel-coated Balloons in Femoral Indication to Defeat Restenosis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on paclitaxel-coated balloons for femoral indications to address restenosis in peripheral artery disease was completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • paclitaxel-coated balloons (paclitaxel-coated balloons)

Snippet

Sponsor: University Hospital, Saarland | Conditions: Peripheral Artery Disease | Phase 3 | Status: COMPLETED